Clinical trials: Cardiac Diseases Requiring Surgery

Aortic Stenosis

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

• Active, not recruiting
• Age: All ages
• Medical device
• Surgery or procedure
• Results posted

To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement.

Trial name

P3 (NCT02675114)

Testing

SAVR, SAPIEN 3 THV

Where

77 sites in United States, Australia and 3 more

Volunteers

1,000 people

Sponsor

Edwards Lifesciences